CPC A61L 31/121 (2013.01) [A61F 2/4455 (2013.01); A61L 27/425 (2013.01); A61L 27/56 (2013.01); A61L 27/58 (2013.01); B05D 1/18 (2013.01); B05D 3/0272 (2013.01); B29C 45/0055 (2013.01); B29C 45/14795 (2013.01); C04B 38/0051 (2013.01); C04B 41/4586 (2013.01); C04B 41/81 (2013.01); C08L 71/12 (2013.01); A61F 2002/30028 (2013.01); A61F 2002/30032 (2013.01); A61F 2002/30062 (2013.01); A61F 2002/30187 (2013.01); A61F 2002/30593 (2013.01); A61F 2/30724 (2013.01); A61F 2002/30957 (2013.01); A61F 2002/30973 (2013.01); A61L 27/46 (2013.01); A61L 2400/08 (2013.01); A61L 2400/18 (2013.01); A61L 2420/02 (2013.01); A61L 2420/04 (2013.01); B29C 2045/0058 (2013.01); B29K 2071/00 (2013.01); B29L 2031/7532 (2013.01); C04B 2235/606 (2013.01)] | 20 Claims |
1. A method for producing a medical implant, the method comprising:
providing a foam with interconnected pores;
impregnating the foam with a slurry of ceramic material to provide a coated foam structure wherein struts of the coated foam structure are coated with the slurry and voids of the coated foam structure are substantially filled with the slurry;
heating and sintering the coated foam structure to provide a ceramic matrix having a plurality of interconnected macropores defined by a plurality of interconnected struts;
sintering the ceramic matrix; and
infusing a filler material into and throughout the macropores,
wherein the interconnected struts each comprise a hollow portion, the hollow portions remaining substantially free of the filler material after the filler material is infused into and throughout the macropores.
|